MarketCap
Facebook
X
Telegram
Teladoc Health Total Assets | TDOC
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Teladoc Health
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.86 B | 3.52 B | 4.39 B | 4.35 B | 17.7 B | 17.8 B | 1.6 B | 1.53 B | 824 M | 304 M | 230 M | 92 M | 27.4 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 17.8 B | 27.4 M | 4.25 B |
Quarterly Total Assets Teladoc Health
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.76 B | 2.81 B | 2.88 B | 2.89 B | 3.44 B | 3.52 B | 3.53 B | 3.52 B | 4.32 B | 4.39 B | 4.33 B | 4.32 B | 4.31 B | 4.35 B | 8.1 B | - | 11.1 B | 17.7 B | 17.7 B | 17.6 B | 17.6 B | 17.8 B | 17.8 B | 17.8 B | 17.8 B | 1.6 B | 1.6 B | 1.6 B | 1.6 B | 1.53 B | 1.53 B | 1.53 B | 1.53 B | 824 M | 824 M | 824 M | 824 M | 304 M | 304 M | 304 M | 304 M | 230 M | 230 M | 230 M | 230 M | 91.8 M | 92 M | 92 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 17.8 B | 91.8 M | 4.9 B |
Total Assets of other stocks in the Health information services industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Computer Programs and Systems
CPSI
|
403 M | - | 4.4 % | $ 133 M |  USA |
 |
Akerna Corp.
KERN
|
1.25 B | - | - | $ 161 M | USA |
 |
MTBC
MTBC
|
87.6 M | - | -0.58 % | $ 51.7 M | USA |
 |
Premier
PINC
|
3.1 B | - | - | $ 2.33 B | USA |
 |
Streamline Health Solutions
STRM
|
35.6 M | - | - | $ 21.4 M | USA |
 |
SCWorx Corp.
WORX
|
7.9 M | - | - | $ 7.71 M | USA |
 |
American Well Corporation
AMWL
|
324 M | $ 12.72 | 2.66 % | $ 204 M | USA |
 |
Evolent Health
EVH
|
1.9 B | $ 3.61 | 4.34 % | $ 412 M | USA |
 |
GoodRx Holdings
GDRX
|
1.4 B | $ 3.36 | 2.44 % | $ 1.2 B | USA |
 |
Health Catalyst
HCAT
|
503 M | $ 1.76 | 0.57 % | $ 123 M | USA |
 |
HealthEquity
HQY
|
3.38 B | $ 91.55 | 1.68 % | $ 7.89 B | USA |
 |
HealthStream
HSTM
|
520 M | $ 31.54 | 2.34 % | $ 947 M | USA |
 |
Omnicell
OMCL
|
1.97 B | $ 34.64 | 3.1 % | $ 1.59 B | USA |
 |
OptimizeRx Corporation
OPRX
|
177 M | $ 8.72 | 1.75 % | $ 162 M | USA |
 |
Progyny
PGNY
|
742 M | $ 25.86 | 2.5 % | $ 2.2 B | USA |
 |
Phreesia
PHR
|
664 M | $ 10.37 | 2.88 % | $ 619 M | USA |
 |
Schrödinger
SDGR
|
726 M | $ 32.6 | 7.56 % | $ 2.39 B | USA |
 |
So-Young International
SY
|
2.65 B | $ 2.74 | 0.36 % | $ 213 M |  China |
 |
10x Genomics
TXG
|
1.04 B | $ 97.74 | 4.53 % | $ 12.2 B | USA |
 |
Veeva Systems
VEEV
|
8.98 B | $ 283.45 | 3.7 % | $ 46.4 B | USA |
 |
Zhongchao
ZCMD
|
24.1 M | $ 1.91 | 3.24 % | $ 6.53 M | China |
 |
NantHealth
NH
|
160 M | - | -46.64 % | $ 10.4 M | USA |
 |
Covetrus
CVET
|
3.41 B | - | - | $ 2.94 B | USA |
 |
1Life Healthcare
ONEM
|
2.43 B | - | - | $ 3.37 B | USA |
 |
R1 RCM
RCM
|
1.45 B | - | - | $ 3.81 B | USA |
 |
Change Healthcare
CHNG
|
9.93 B | - | - | $ 9.03 B | USA |
 |
Signify Health
SGFY
|
1.74 B | - | -0.02 % | $ 7.21 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
384 M | - | - | $ 255 M | USA |
 |
Cerner Corporation
CERN
|
7.43 B | - | - | $ 27.9 B | USA |
 |
iCAD
ICAD
|
37.5 M | - | - | $ 102 M | USA |
 |
NextGen Healthcare
NXGN
|
896 M | - | - | $ 1.6 B | USA |
 |
Accolade
ACCD
|
788 M | - | 0.29 % | $ 206 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
1.35 B | - | -10.39 % | $ 886 M | USA |
 |
Castlight Health, Inc.
CSLT
|
167 M | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
1.33 B | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
1.97 B | - | - | $ 6.37 B | USA |